Tilray Makes a Bold Prediction on Cannabis Legalization in the US

Tilray Makes a Bold Prediction on Cannabis Legalization in the US

In the earlier part of this series, we looked at how Canopy Growth (WEED) is testing hemp-based CBD products to lower anxiety in dogs. While talking about the different uses of hemp-based CBD in its Q2 2019 earnings call, Canopy Growth said that it could develop anti-inflammatory products such as sports drinks for the US market. Canopy Growth is preparing for the US market, but Tilray (TLRY) is not far behind.